ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Hofland, Johannes ^a   Hofland, Leo J ^a   Van Koetsveld, Peter M ^a   Steenbergen, Jacobie ^a   De Herder, Wouter W ^a   Van Eijck, Casper H ^a   De Krijger, Ronald R ^a   Van Nederveen, Francien H ^b   Van Aken, Maarten O ^c   De Groot, Johannes W ^d   Links, Thera P ^e   De Jong, Frank H ^a   Feelders, Richard A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Erasmus Medical Center ^*  (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d ISALA HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

AIMAH; Arginine vasopressin; Cushing's syndrome

Indexed keywords

ARGININE VASOPRESSIN 1A RECEPTOR; ARGIPRESSIN RECEPTOR; CATECHOLAMINE; CORTICOTROPIN; HYDROCORTISONE; METOCLOPRAMIDE; STEROID 11BETA MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENAL CELL; ADRENAL CORTEX CELL; ADRENAL GLAND; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN INDEPENDENT MACRONODULAR ADRENOCORTICAL HYPERPLASIA; CUSHING SYNDROME; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; IN VITRO STUDY; IN VIVO STUDY; MALE; PROTEIN EXPRESSION;

ADRENOCORTICOTROPIC HORMONE; AGED; ARGININE VASOPRESSIN; CATECHOLAMINES; CELLS, CULTURED; CUSHING SYNDROME; FEMALE; GLUCAGON; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYDROCORTISONE; MALE; METOCLOPRAMIDE; MIDDLE AGED; STEROID 11-BETA-HYDROXYLASE; THYROTROPIN-RELEASING HORMONE;

EID: 84883683607     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-142     Document Type: Article

References (43)

1. Approach to the patient with possible Cushing's syndrome. Boscaro M, Arnaldi G, J Clin Endocrinol Metab 2009 94 3121 3131 10.1210/jc.2009-0612 19734443
2. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Lacroix A, Ndiaye N, Tremblay J, Hamet P, Endocr Rev 2001 22 75 110 10.1210/er.22.1.75 11159817 (Pubitemid 32187804)
3. Gastric inhibitory polypeptide-dependent cortisol hypersecretion-a new cause of Cushing's syndrome. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taillefer R, et al. N Engl J Med 1992 327 974 980 10.1056/NEJM199210013271402 1325608
4. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J, N Engl J Med 1992 327 981 986 10.1056/NEJM199210013271403 1325609
5. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. de Herder WW, Hofland LJ, Usdin TB, de Jong FH, Uitterlinden P, van Koetsveld P, Mezey E, Bonner TI, Bonjer HJ, Lamberts SW, J Clin Endocrinol Metab 1996 81 3168 3172 10.1210/jc.81.9.3168 8784063 (Pubitemid 26296182)
6. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P, N Engl J Med 1997 337 1429 1434 10.1056/NEJM199711133372004 9358140 (Pubitemid 27497890)
7. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome. Assie G, Louiset E, Sturm N, Rene-Corail F, Groussin L, Bertherat J, Thomas M, Lefebvre H, Feige JJ, Clauser E, et al. J Clin Endocrinol Metab 2010 95 253 262 10.1210/jc.2009-2281 20660048
8. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H, J Clin Endocrinol Metab 1995 80 2336 2341 10.1210/jc.80.8.2336 7629226
9. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. Lacroix A, Tremblay J, Touyz RM, Deng LY, Lariviere R, Cusson JR, Schiffrin EL, Hamet P, J Clin Endocrinol Metab 1997 82 2414 2422 10.1210/jc.82.8.2414 9253310 (Pubitemid 27337849)
10. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. Lacroix A, Hamet P, Boutin JM, N Engl J Med 1999 341 1577 1581 10.1056/NEJM199911183412104 10564687
11. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, de Jong FH, Bonjer HJ, Clark AJ, van der Lely AJ, de Herder WW, J Clin Endocrinol Metab 2003 88 230 237 10.1210/jc.2002-020621 12519858 (Pubitemid 36115171)
12. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, Kuhn JM, Lacroix A, Tabarin A, Young J, et al. J Clin Endocrinol Metab 2003 88 248 254 10.1210/jc.2002-021107 12519861 (Pubitemid 36115174)
13. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Vezzosi D, Cartier D, Regnier C, Otal P, Bennet A, Parmentier F, Plantavid M, Lacroix A, Lefebvre H, Caron P, Eur J Endocrinol 2007 156 21 31 10.1530/eje.1.02324 17218722 (Pubitemid 46553900)
14. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II. Nakamura Y, Son Y, Kohno Y, Shimono D, Kuwamura N, Koshiyama H, Sasano H, Matsuda T, Endocrine 2001 15 57 61 10.1385/ENDO:15:1:057 11572327 (Pubitemid 32802632)
15. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia. Miguel V, Redal MA, Viale ML, Kahan M, Glerean M, Beskow A, Fainstein Day P, Medicina (B Aires) 2010 70 254 256
16. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome. Libe R, Coste J, Guignat L, Tissier F, Lefebvre H, Barrande G, Ajzenberg C, Tauveron I, Clauser E, Dousset B, et al. Eur J Endocrinol 2010 163 129 138 10.1530/EJE-10-0195 20378721
17. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Lacroix A, Bourdeau I, Lampron A, Mazzuco TL, Tremblay J, Hamet P, Clin Endocrinol (Oxf) 2010 73 1 15
18. Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators. Bourdeau I, Antonini SR, Lacroix A, Kirschner LS, Matyakhina L, Lorang D, Libutti SK, Stratakis CA, Oncogene 2004 23 1575 1585 10.1038/sj.onc.1207277 14767469 (Pubitemid 38406520)
19. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. Hsiao HP, Kirschner LS, Bourdeau I, Keil MF, Boikos SA, Verma S, Robinson-White AJ, Nesterova M, Lacroix A, Stratakis CA, J Clin Endocrinol Metab 2009 94 2930 2937 10.1210/jc.2009-0516 19509103
20. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds. Gagliardi L, Hotu C, Casey G, Braund WJ, Ling KH, Dodd T, Manavis J, Devitt PG, Cutfield R, Rudzki Z, et al. Clin Endocrinol (Oxf) 2009 70 883 891 10.1111/j.1365-2265.2008.03471. x
21. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M, Endocrinology 2006 147 782 790 16254030 (Pubitemid 43112995)
22. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. Mazzuco TL, Chabre O, Feige JJ, Thomas M, J Clin Endocrinol Metab 2006 91 196 203 10.1210/jc.2005-1975 16249277 (Pubitemid 43069138)
23. Clinical review: diagnosis and treatment of subclinical hypercortisolism. Chiodini I, J Clin Endocrinol Metab 2011 96 1223 1236 10.1210/jc.2010-2722 21367932
24. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. Lamberts SW, Bons EG, Bruining HA, de Jong FH, J Pharmacol Exp Ther 1987 240 259 264 3027305 (Pubitemid 17235446)
25. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms. Hofland J, Timmerman MA, de Herder WW, van Schaik RH, de Krijger RR, de Jong FH, Clin Endocrinol (Oxf) 2006 65 792 799 10.1111/j.1365-2265.2006.02668.x (Pubitemid 44772360)
26. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors? Chai W, Hofland J, Jansen PM, Garrelds IM, de Vries R, van den Bogaerdt AJ, Feelders RA, de Jong FH, Danser AH, J Hypertens 2010 28 1044 1053 10.1097/HJH.0b013e328335c381 20179635
27. Rapid decrease in adrenal responsiveness to ACTH stimulation after successful pituitary surgery in patients with Cushing's disease. Alwani RA, de Herder WW, de Jong FH, Lamberts SW, van der Lely AJ, Feelders RA, Clin Endocrinol (Oxf) 2011 75 602 607 10.1111/j.1365-2265.2011.04130.x
28. Regulation by adrenocorticotropin (ACTH), angiotensin II, transforming growth factor-beta, and insulin-like growth factor I of bovine adrenal cell steroidogenic capacity and expression of ACTH receptor, steroidogenic acute regulatory protein, cytochrome P450c17, and 3beta-hydroxysteroid dehydrogenase. Le Roy C, Li JY, Stocco DM, Langlois D, Saez JM, Endocrinology 2000 141 1599 1607 10.1210/en.141.5.1599 10803567 (Pubitemid 32274387)
29. Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness. Hofland J, Delhanty PJ, Steenbergen J, Hofland LJ, van Koetsveld PM, van Nederveen FH, de Herder WW, Feelders RA, de Jong FH, J Clin Endocrinol Metab 2012 97 747 754 10.1210/jc.2011-2328 22419722
30. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. Arnaldi G, Gasc JM, de Keyzer Y, Raffin-Sanson ML, Perraudin V, Kuhn JM, Raux-Demay MC, Luton JP, Clauser E, Bertagna X, J Clin Endocrinol Metab 1998 83 2029 2035 10.1210/jc.83.6.2029 9626135 (Pubitemid 28496333)
31. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia. Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, Suwa T, Hanafusa J, Daido H, Morita H, Yasuda K, J Clin Endocrinol Metab 2002 87 5706 5713 10.1210/jc.2002-020067 12466375 (Pubitemid 36034380)
32. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. Perraudin V, Delarue C, De Keyzer Y, Bertagna X, Kuhn JM, Contesse V, Clauser E, Vaudry H, J Clin Endocrinol Metab 1995 80 2661 2667 10.1210/jc.80.9.2661 7673409
33. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome. de Groot JW, Links TP, Themmen AP, Looijenga LH, de Krijger RR, van Koetsveld PM, Hofland J, van den Berg G, Hofland LJ, Feelders RA, Eur J Endocrinol 2010 163 293 299 10.1530/EJE-10-0058 20460422
34. Non-peptide arginine-vasopressin antagonists: the vaptans. Decaux G, Soupart A, Vassart G, Lancet 2008 371 1624 1632 10.1016/S0140-6736(08)60695-9 18468546 (Pubitemid 351626846)
35. Serotonergic regulation of adrenocortical function. Lefebvre H, Contesse V, Delarue C, Vaudry H, Kuhn JM, Horm Metab Res 1998 30 398 403 10.1055/s-2007-978904 9694569 (Pubitemid 28308017)
36. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype. Lefebvre H, Contesse V, Delarue C, Feuilloley M, Hery F, Grise P, Raynaud G, Verhofstad AA, Wolf LM, Vaudry H, Neuroscience 1992 47 999 1007 10.1016/0306-4522(92)90047-6 1374544
37. GIP-dependent adrenal Cushing's syndrome with incomplete suppression of ACTH. Croughs RJ, Zelissen PM, van Vroonhoven TJ, Hofland LJ, N'Diaye N, Lacroix A, de Herder WW, Clin Endocrinol (Oxf) 2000 52 235 240 10.1046/j.1365-2265. 2000.00932.x (Pubitemid 30108271)
38. Food-dependent Cushing's syndrome. Messidoro C, Elte JW, Castro Cabezas M, van Agteren M, Lacroix A, de Herder WW, Neth J Med 2009 67 187 190 19581669
39. Diurnal cortisol peaks and their relationships to meals. Follenius M, Brandenberger G, Hietter B, J Clin Endocrinol Metab 1982 55 757 761 10.1210/jcem-55-4-757 7202017 (Pubitemid 13232120)
40. Pituitary hormone release in response to food ingestion: evidence for neuroendocrine signals from gut to brain. Ishizuka B, Quigley ME, Yen SS, J Clin Endocrinol Metab 1983 57 1111 1116 10.1210/jcem-57-6-1111 6630409 (Pubitemid 14209405)
41. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H, Lefebvre H, J Clin Endocrinol Metab 2005 90 1302 1310 15585558 (Pubitemid 40463980)
42. Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. Louiset E, Contesse V, Groussin L, Cartier D, Duparc C, Barrande G, Bertherat J, Vaudry H, Lefebvre H, J Clin Endocrinol Metab 2006 91 4578 4586 10.1210/jc.2006-0538 16954157 (Pubitemid 44833441)
43. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. Perraudin V, Delarue C, Lefebvre H, Contesse V, Kuhn JM, Vaudry H, J Clin Endocrinol Metab 1993 76 1522 1528 10.1210/jc.76.6.1522 7684742 (Pubitemid 23164372)